Zydus Cadila receives USFDA approval for mesalamine tablets
Zydus Cadila has received the US health regulator’s approval for marketing the mesalamine tablets that is used in treating uclerative colitis. The company has said...
RELIANCE 1,219.30 +33.70 (2.84%) 
TCS 3,232.30 -13.80 (-0.43%) 
HDFCBANK 1,806.60 +41.10 (2.33%) HINDUNILVR 2,366.60 +17.15 (0.73%) INFY 1,410.60 +6.40 (0.46%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,757.30 +41.60 (2.42%) KOTAKBANK 2,111.50 +58.45 (2.85%) ICICIBANK 1,311.85 +11.35 (0.87%) ITC 421.80 +5.65 (1.36%) BAJFINANCE 8,926.70 +199.65 (2.29%) MARUTI 11,602.80 +140.85 (1.23%) HCLTECH 1,390.30 +9.85 (0.71%) SBIN 754.05 +12.00 (1.62%) NESTLEIND 2,360.85 +16.35 (0.70%) ASIANPAINT 2,394.20 -15.50 (-0.64%) WIPRO 239.80 +3.15 (1.33%) DMART 4,122.10 -18.00 (-0.43%) AXISBANK 1,069.35 +7.70 (0.73%) LT 3,117.05 +57.95 (1.89%) HDFCLIFE 685.35 +0.55 (0.08%) SUNPHARMA 1,687.55 +35.45 (2.15%) ULTRACEMCO 11,506.15 +113.10 (0.99%) ONGC 230.35 +8.15 (3.67%) BAJAJFINSV 1,945.65 +49.25 (2.60%) BPCL 293.05 +5.20 (1.81%) POWERGRID 304.10 +10.80 (3.68%) TITAN 3,234.90 +59.70 (1.88%) BRITANNIA 5,349.45 +13.00 (0.24%) NTPC 360.10 +11.35 (3.25%)
TCS 3,232.30 -13.80 (-0.43%) HDFCBANK 1,806.60 +41.10 (2.33%) HINDUNILVR 2,366.60 +17.15 (0.73%) INFY 1,410.60 +6.40 (0.46%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,757.30 +41.60 (2.42%) KOTAKBANK 2,111.50 +58.45 (2.85%) ICICIBANK 1,311.85 +11.35 (0.87%) ITC 421.80 +5.65 (1.36%) BAJFINANCE 8,926.70 +199.65 (2.29%) MARUTI 11,602.80 +140.85 (1.23%) HCLTECH 1,390.30 +9.85 (0.71%) SBIN 754.05 +12.00 (1.62%) NESTLEIND 2,360.85 +16.35 (0.70%) ASIANPAINT 2,394.20 -15.50 (-0.64%) WIPRO 239.80 +3.15 (1.33%) DMART 4,122.10 -18.00 (-0.43%) AXISBANK 1,069.35 +7.70 (0.73%) LT 3,117.05 +57.95 (1.89%) HDFCLIFE 685.35 +0.55 (0.08%) SUNPHARMA 1,687.55 +35.45 (2.15%) ULTRACEMCO 11,506.15 +113.10 (0.99%) ONGC 230.35 +8.15 (3.67%) BAJAJFINSV 1,945.65 +49.25 (2.60%) BPCL 293.05 +5.20 (1.81%) POWERGRID 304.10 +10.80 (3.68%) TITAN 3,234.90 +59.70 (1.88%) BRITANNIA 5,349.45 +13.00 (0.24%) NTPC 360.10 +11.35 (3.25%) 